Skip to main content
Clinical Trials/EUCTR2005-001466-14-GB
EUCTR2005-001466-14-GB
Active, not recruiting
Phase 1

A Proof of Concept Study to Investigate the use of Simvastatin as a Putative Anti-inflammatory Agent in Asthma - Simvastatin in Asthma

niversity of Dundee0 sites20 target enrollmentApril 19, 2005

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Asthma
Sponsor
niversity of Dundee
Enrollment
20
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 19, 2005
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity of Dundee

Eligibility Criteria

Inclusion Criteria

  • Adult asthmatics (over 18 years) with stable mild to moderate asthma.
  • FEV1 \> 60%
  • FENO \> 20ppb
  • MCh PC10 \< 2mg/mL
  • Induced sputum eosinophil count \>3%
  • Ability to perform tests and remain compliant with protocol
  • Good inhaler technique
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • Potential or actual contra\-indication to Simvastatin in particular liver disease, renal failure, current or previous excess alcohol intake, elevated CK, pregnancy and concomitant use of medications known to interact adversly with simvastatin.
  • Known or suspoected hypersensitivity to any of the other IMP's
  • Inability to to provide informed consent
  • Recent respiratory tract infection
  • Recent use of oral corticosteroids
  • Significant concomitant respiratory disease
  • Current smokers
  • Any other condition that may, in the opinion of the investigators, endanger the health or safety of the participant

Outcomes

Primary Outcomes

Not specified

Similar Trials